Enforcement Report - Week of August 18, 2021
Enforcement Report - Week of October 2, 2019
Strides Pharma`s Generic Ethosuximide Receives Approval in US
Strides Pharma Global Pte., Singapore, has received approval for ethosuximide softgel capsules USP, 250 mg from the United States Food & Drug Administration (FDA). The product was approved in the first review cycle by the US FDA in less than 10 months of filing under the GDUFA II regime. The product is a generic version of Zarontin capsules, 250 mg, of Pfizer Inc.
Enforcement Report - Week of September 12, 2018